<?xml version="1.0" encoding="UTF-8"?>
<p id="Par55">A study carried out in adult patients with hematological malignancies showed that hRV was by far the most frequently identified pathogen (in about 40% of symptomatic patients); in detail, 32% of the total patients with hRV (110) were affected by ALL or myelodysplastic syndrome (MDS), 19% by chronic leukemia, and 49% by lymphoma, multiple myeloma (MM) or other. In addition, 45% of these patients were also HSCT recipients [
 <xref ref-type="bibr" rid="CR33">33</xref>].
</p>
